基于分子对接与分子动力学模拟探究二陈汤抑制肥胖的机制OA
Exploring the mechanism of Erchen Decoction(二陈汤)in inhibiting obesity based on molecu-lar docking and molecular dynamics simulation
目的 运用分子对接、分子动力学和实验验证的方法探索中药复方二陈汤抑制肥胖的机制.方法 采用数据库筛选二陈汤与肥胖的靶点,进行KEGG分析,UPLC-MS检测二陈汤成分,将其成分与腺苷酸激活蛋白激酶(AMPK)进行分子对接、分子动力学模拟分析.实验选用SPF级雄性SD大鼠建立高脂饮食肥胖模型.大鼠随机分为对照组、模型组、二陈汤高(1 740 mg·kg-1·d-1)、低剂量组(435 mg·kg-1·d-1).高脂饮食喂养,对应二陈汤高、低剂量灌胃处理,12周后收集体质量、血脂四项、脂肪组织HE染色结果,Western blot法检测棕色脂肪组织AMPK、磷酸化AMPK(pAMPK)、过氧化物酶体增殖物激活受体γ辅激活因子1α(PGC-1α)、解偶联蛋白-1(UCP-1)的蛋白表达水平.结果 获得二陈汤与肥胖交集靶点374个,对其进行富集分析显示主要涉及AMPK信号通路,UPLC-MS显示二陈汤内含川陈皮素、橙皮苷等主要成分.分子对接结果显示,二陈汤内川陈皮素等活性成分与上述通路中AMPK具有较好的结合能力动物实验显示,与对照组比较,模型组大鼠体质量、甘油三酯等水平明显升高(P<0.05),脂肪空泡面积增大,棕色脂肪组织PGC-1α、UCP-1、pAMPK的蛋白水平降低(P<0.05).与模型组比较,二陈汤高、低剂量组体质量、甘油三酯等水平显著下调(P<0.05),棕色脂肪组织PGC-1α、UCP-1、pAMPK蛋白表达显著上调(P<0.05).分子动力学模拟进一步验证川陈皮素与AMPK复合物结合稳定,其结合位点位于AMPK激活剂的口袋中.结论 二陈汤可降低食源性肥胖大鼠的体质量及血脂,其部分机制与激活棕色脂肪中AMPK通路相关.
Objective To explore the potential mechanism of the Chinese herbal compound Erchen Decoction(二陈汤,ECD)in treat-ing high-fat diet-induced obesity using multiple approaches.Methods The SymMap database was used to screen the common targets of ECD and obesity,and KEGG analysis was performed on these targets.The main active components of ECD were detected by UPLC-MS,and molecular docking visualization and molecular dynamics simulation of ECD components with the main proteins in the KEGG pathway were conducted.SPF male SD rats were randomly divided into control group,model group,ECD low/high-dose group.Body weight,blood lipid levels,and HE staining of adipose tissue were assessed.The protein expression levels of AMPK,phosphorylated AMPK(pAMPK),peroxisome proliferator-activated receptor gamma coactivator 1-alpha(PGC-1α),and uncoupling protein-1(UCP-1)in brown adipose tissue were detected by Western blot(WB).Results A total of 374 common targets between ECD and obesity were identi-fied.KEGG analysis indicated that these targets were primarily involved in the AMPK signaling pathway,and UPLC-MS revealed that ECD contained nobiletin,hesperidin,and other major components.Molecular docking confirmed that nobiletin exhibited stable binding with AMPK.Animal experiments showed that compared with the control group,the model group had significantly increased body weight,triglyceride levels,and total cholesterol levels(P<0.05),significantly enlarged adipose cell size,and significantly decreased protein expression levels of PGC-1α,UCP-1,and pAMPK in brown adipose tissue(P<0.05).Compared with the model group,ECD treatment significantly reduced body weight and blood lipid levels,decreased adipose cell size,and increased the protein expression levels of PGC-1α,UCP-1,and pAMPK in brown adipose tissue(P<0.05).Molecular dynamics simulations further confirmed that the nobiletin-AMPK complex binding was stable,with the binding site located in the activator pocket of AMPK.Conclusion ECD may reduce body weight and blood lipids in rats with high-fat diet(HFD)-induced obesity,and the mechanism may involve activation of the AMPK pathway in brown adipose tissue.
郑慜成;杨侃霖;马永杰;程亚;李润美;许洁安;徐进文
广州中医药大学,广东 广州 510006广州中医药大学,广东 广州 510006广州中医药大学,广东 广州 510006广州中医药大学,广东 广州 510006广州中医药大学,广东 广州 510006广州中医药大学,广东 广州 510006广州中医药大学,广东 广州 510006
医药卫生
二陈汤肥胖分子对接分子动力学腺苷酸激活蛋白激酶
Erchen Decoction(二陈汤)ObesityMolecular dockingMolecular dynamicsAMPK
《时珍国医国药》 2026 (6)
1008-1016,9
国家自然科学基金(81774107)广州中医药大学校院联合科技创新基金项目(GZYZS2024U03)
评论